Changchun High-Tech Industries (Group) (000661) Fundamentals 2026 — P/E 368.8x, Revenue Analysis | SniperIQ
Changchun High-Tech Industries (Group) (000661) is a CN-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of ¥31.6B, trading at ¥77.44 on the SHZ. This SniperIQ fundamentals page covers Changchun High-Tech Industries (Group)'s valuation (P/E 368.8x, P/B 1.4x), profitability (net margin -0.4%), revenue (¥12.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Changchun High-Tech Industries (Group)'s market cap?
Changchun High-Tech Industries (Group) (000661) has a market capitalization of approximately ¥31.6B, trading at ¥77.44 on the SHZ. Market cap moves with the live share price.
What is Changchun High-Tech Industries (Group)'s P/E ratio?
Changchun High-Tech Industries (Group)'s trailing twelve-month P/E ratio is 368.8x, with a price-to-book (P/B) of 1.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Changchun High-Tech Industries (Group)?
Changchun High-Tech Industries (Group) runs a net profit margin of -0.4%, a gross margin of 79.5%, and an operating margin of 1.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Changchun High-Tech Industries (Group) generate?
Changchun High-Tech Industries (Group) reported revenue of ¥12.1B for fiscal year 2025, with net income of ¥155M and earnings per share (EPS) of 0.39. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Changchun High-Tech Industries (Group) pay a dividend?
Changchun High-Tech Industries (Group) offers a trailing dividend yield of about 0.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Changchun High-Tech Industries (Group) financially healthy?
Changchun High-Tech Industries (Group) carries a debt-to-equity ratio of 0.09x and a current ratio of 3.52x, with a market beta of 0.43. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Changchun High-Tech Industries (Group) a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Changchun High-Tech Industries (Group) (000661) the key facts are: market cap ¥31.6B, P/E 368.8x, revenue ¥12.1B, 52-week range 61.09-141.77. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Changchun High-Tech Industries (Group)'s full fundamentals live
Get Changchun High-Tech Industries (Group)'s 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.